Marc G. Ghany

23.3k total citations · 4 hit papers
188 papers, 15.1k citations indexed

About

Marc G. Ghany is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marc G. Ghany has authored 188 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Hepatology, 163 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Marc G. Ghany's work include Hepatitis C virus research (156 papers), Liver Disease Diagnosis and Treatment (130 papers) and Hepatitis B Virus Studies (125 papers). Marc G. Ghany is often cited by papers focused on Hepatitis C virus research (156 papers), Liver Disease Diagnosis and Treatment (130 papers) and Hepatitis B Virus Studies (125 papers). Marc G. Ghany collaborates with scholars based in United States, Canada and France. Marc G. Ghany's co-authors include Leonard B. Seeff, David L. Thomas, Doris B. Strader, Anna S. Lok, Timothy R. Morgan, T. Jake Liang, Jay H. Hoofnagle, David E. Kleiner, Herbert L. Bonkovsky and Adrian M. Di Bisceglie and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Marc G. Ghany

180 papers receiving 14.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

2008 2.3k citations Marc G. Ghany, Doris B. Strader et al. Hepatology profile →
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

2011 828 citations Marc G. Ghany, David R. Nelson et al. Hepatology profile →
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡

2004 587 citations Glen Lutchman, Alejandro Soza et al. Hepatology profile →
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

2019 569 citations Marc G. Ghany, Timothy R. Morgan et al. Hepatology profile →

Peers

Countries citing papers authored by Marc G. Ghany

Since Specialization

Citations

This map shows the geographic impact of Marc G. Ghany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc G. Ghany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc G. Ghany more than expected).

Fields of papers citing papers by Marc G. Ghany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc G. Ghany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc G. Ghany. The network helps show where Marc G. Ghany may publish in the future.

Co-authorship network of co-authors of Marc G. Ghany

This figure shows the co-authorship network connecting the top 25 collaborators of Marc G. Ghany. A scholar is included among the top collaborators of Marc G. Ghany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc G. Ghany. Marc G. Ghany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign‐Born: The FOCUS‐HBV Multicentre Cohort 2025 ·Alimentary Pharmacology & Therapeutics ·Kali Zhou, (unknown), Christopher K. Wong, Amol S. Rangnekar, (unknown), (unknown), Andreas Keller, Coleman I. Smith, (unknown), (unknown), (unknown), (unknown), Marc G. Ghany, Jennifer L. Dodge, Norah A. Terrault, Christine Hsu	0
2	AASLD IDSA Practice Guideline on treatment of chronic hepatitis B 2025 ·Hepatology ·Marc G. Ghany, Calvin Q. Pan, Anna S. Lok, Jordan J. Feld, Joseph K. Lim, Su H. Wang, (unknown), (unknown), (unknown), (unknown), Mark S. Sulkowski, Norberto Rodriguez‐Baez, Jau‐Nian Chen, M. Hassan Murad, Mohammad Khademloo, Norah A. Terrault	3
3	Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B 2024 ·Current Hepatology Reports ·(unknown), Marc G. Ghany	6
4	Mo1570 DEFYING DANGER: ASSESSING OLOROFIM'S IMPACT ON THE LIVER - A CASE REPORT OF SEVERE DILI AND SUCCESSFUL RECHALLENGE 2024 ·Gastroenterology ·(unknown), (unknown), (unknown), Marc G. Ghany	0
5	Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations 2023 ·Clinical Infectious Diseases ·Jordan J. Feld, Julie Bruneau, Gregory J. Dore, Marc G. Ghany, Bettina E. Hansen, Mark Sulkowski, David L. Thomas	6
6	Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B 2022 ·The American Journal of Gastroenterology ·Norah A. Terrault, Anna S. Lok, Abdus S. Wahed, Marc G. Ghany, Robert P. Perrillo, Michael Fried, David Wong, Mandana Khalili, Daryl Lau, Richard K. Sterling, Adrian M. Di Bisceglie, Mauricio Lisker‐Melman, Stewart Cooper, Ray Chung, Keyur Patel, Lewis R. Roberts, Steven H. Belle, Harry L.A. Janssen	11
7	Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection 2022 ·Clinical Gastroenterology and Hepatology ·Jordan J. Feld, Wendy C. King, Marc G. Ghany, Kyong‐Mi Chang, Norah A. Terrault, Robert P. Perrillo, Mandana Khalili, Amanda S. Hinerman, Harry L.A. Janssen, Anna S. Lok	3
8	Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection 2021 ·Science Translational Medicine ·Akira Nishio, (unknown), Kazuyo Takeda, (unknown), Zu‐Xi Yu, Heiyoung Park, Kristin Valdez, Marc G. Ghany, Barbara Rehermann	35
9	A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection 2021 ·Clinical Gastroenterology and Hepatology ·Raymond Chung, Wendy C. King, Marc G. Ghany, Mauricio Lisker‐Melman, Amanda S. Hinerman, Mandana Khalili, Mark Sulkowski, Mamta K. Jain, Eun-Young Choi, Michael A. Nalesnik, Atul K. Bhan, Gavin Cloherty, David Wong, Richard K. Sterling	3
10	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function 2015 ·Gastroenterology ·Elisavet Serti, Xenia Chepa-Lotrea, Yun Ju Kim, (unknown), Nancy Fryzek, T. Jake Liang, Marc G. Ghany, Barbara Rehermann	192
11	Long-term therapy of chronic delta hepatitis with peginterferon alfa 2014 ·Alimentary Pharmacology & Therapeutics ·Theo Heller, Yaron Rotman, Christopher Koh, Shauna Clark, Vanessa Haynes–Williams, Richard Chang, Robert P. McBurney, Peter Schmid, J. Albrecht, David E. Kleiner, Marc G. Ghany, T. Jake Liang, Jay H. Hoofnagle	81
12	An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases breakdown → 2011 ·Hepatology ·Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas, Leonard B. Seeff	828
13	Low‐ and standard‐dose peginterferon alfa‐2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response 2010 ·Alimentary Pharmacology & Therapeutics ·Yaron Rotman, Brian B. Borg, Alejandro Soza, Jordan J. Feld, Apurva A. Modi, Rohit Loomba, Glen Lutchman, Elenita Rivera, Edward Doo, Marc G. Ghany, Theo Heller, Avidan U. Neumann, T. Jake Liang, Jay H. Hoofnagle	7
14	Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial 2009 ·Gastroenterology ·Mitchell L. Shiffman, Chihiro Morishima, Jules L. Dienstag, Karen L. Lindsay, John C. Hoefs, William M. Lee, Elizabeth C. Wright, Deepa Naishadham, Gregory T. Everson, Anna S. Lok, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany	30
15	Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial 2009 ·Gastroenterology ·James E. Everhart, Anna S. Lok, Hae‐Young Kim, Timothy R. Morgan, Karen L. Lindsay, Raymond T. Chung, Herbert L. Bonkovsky, Marc G. Ghany	106
16	Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease 2008 ·Gastroenterology ·Anna S. Lok, Leonard B. Seeff, Timothy R. Morgan, Adrian M. Di Bisceglie, Richard K. Sterling, Teresa M. Curto, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, Marc G. Ghany, Chihiro Morishima, Zachary Goodman	452
17	Blunted Cytopenias and Weight Loss: New Correlates of Virologic Null Response to Re-treatment of Chronic Hepatitis C 2008 ·Clinical Gastroenterology and Hepatology ·Karen L. Lindsay, Chihiro Morishima, Elizabeth C. Wright, Jules L. Dienstag, Mitchell L. Shiffman, Gregory T. Everson, Anna S. Lok, Herbert L. Bonkovsky, William M. Lee, Timothy R. Morgan, Marc G. Ghany	22
18	Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial 2007 ·Hepatology ·Leonard B. Seeff, Teresa M. Curto, Gyöngyi Szabó, Gregory T. Everson, Herbert L. Bonkovsky, Jules L. Dienstag, Mitchell L. Shiffman, Karen L. Lindsay, Anna S. Lok, Adrian M. Di Bisceglie, William M. Lee, Marc G. Ghany	98
19	Portal Hypertensive Gastropathy in Chronic Hepatitis C Patients with Bridging Fibrosis and Compensated Cirrhosis: Results from the HALT-C Trial 2006 ·The American Journal of Gastroenterology ·Robert J. Fontana, Arun J. Sanyal, Savant Mehta, Michael C. Doherty, Brent A. Neuschwander‐Tetri, Gregory T. Everson, Jeffrey Kahn, Peter F. Malet, Muhammad Y. Sheikh, Raymond Chung, Marc G. Ghany, David R. Gretch, (unknown)	53
20	A rapid immunochromatographic assay for hepatitis B virus screening 2003 ·Journal of Viral Hepatitis ·Daryl Lau, Hongxia Ma, Stanley M. Lemon, Edward Doo, Marc G. Ghany, Emil Miskovsky, Gail L. Woods, (unknown), J. H. Hoofnagle	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact